Dimensional Fund Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $100M | Buy |
5,794,263
+103,677
| +2% | +$1.42M | 0.02% | 1174 |
|
|
2026
Q1 | $70.7M | Buy |
5,690,586
+81,546
| +1% | +$1.09M | 0.01% | 1306 |
|
|
2025
Q4 | $70.7M | Buy |
5,609,040
+177,906
| +3% | +$2.04M | 0.01% | 1311 |
|
|
2025
Q3 | $54.4M | Buy |
5,431,134
+133,764
| +3% | +$1.2M | 0.01% | 1477 |
|
|
2025
Q2 | $42.9M | Buy |
5,297,370
+194,214
| +4% | +$1.46M | 0.01% | 1588 |
|
|
2025
Q1 | $42.8M | Buy |
5,103,156
+111,454
| +2% | +$930K | 0.01% | 1554 |
|
|
2024
Q4 | $39.5M | Buy |
4,991,702
+278,653
| +6% | +$2.34M | 0.01% | 1660 |
|
|
2024
Q3 | $39.2M | Buy |
4,713,049
+429,121
| +10% | +$3.36M | 0.01% | 1649 |
|
|
2024
Q2 | $27.2M | Buy |
4,283,928
+641,405
| +18% | +$4.07M | 0.01% | 1804 |
|
|
2024
Q1 | $22.1M | Buy |
3,642,523
+819,910
| +29% | +$4.62M | 0.01% | 1930 |
|
|
2023
Q4 | $17.1M | Buy |
2,822,613
+847,801
| +43% | +$3.78M | 0.01% | 2062 |
|
|
2023
Q3 | $8.34M | Buy |
1,974,812
+776,702
| +65% | +$2.9M | ﹤0.01% | 2350 |
|
|
2023
Q2 | $3.71M | Sell |
1,198,110
-143,693
| -11% | -$306K | ﹤0.01% | 2617 |
|
|
2023
Q1 | $1.86M | Buy |
+1,341,803
| New | +$2.67M | ﹤0.01% | 2758 |
|
|
2022
Q3 | $2.75M | Sell |
1,360,021
-449,771
| -25% | -$1.26M | ﹤0.01% | 2615 |
|
|
2022
Q2 | $5.76M | Buy |
1,809,792
+170,470
| +10% | +$618K | ﹤0.01% | 2411 |
|
|
2022
Q1 | $6.84M | Buy |
1,639,322
+124,301
| +8% | +$550K | ﹤0.01% | 2440 |
|
|
2021
Q4 | $7.26M | Buy |
1,515,021
+172,629
| +13% | +$861K | ﹤0.01% | 2435 |
|
|
2021
Q3 | $7.17M | Sell |
1,342,392
-42,041
| -3% | -$212K | ﹤0.01% | 2461 |
|
|
2021
Q2 | $7.09M | Buy |
1,384,433
+466,726
| +51% | +$2.65M | ﹤0.01% | 2491 |
|
|
2021
Q1 | $6.18M | Buy |
917,707
+469,059
| +105% | +$2.6M | ﹤0.01% | 2501 |
|
|
2020
Q4 | $2.05M | Buy |
448,648
+152,832
| +52% | +$677K | ﹤0.01% | 2801 |
|
|
2020
Q3 | $1.15M | Buy |
295,816
+98,354
| +50% | +$421K | ﹤0.01% | 2899 |
|
|
2020
Q2 | $940K | Buy |
197,462
+186,590
| +1,716% | +$768K | ﹤0.01% | 2955 |
|
|
2020
Q1 | $38K | Buy |
+10,872
| New | +$46K | ﹤0.01% | 3332 |
|
|
2019
Q3 | – | Sell |
-51,841
| Closed | -$372K | – | 3419 |
|
|
2019
Q2 | $372K | Sell |
51,841
-157,580
| -75% | -$1.61M | ﹤0.01% | 3238 |
|
|
2019
Q1 | $2.97M | Sell |
209,421
-754,381
| -78% | -$9.97M | ﹤0.01% | 2800 |
|
|
2018
Q4 | $13M | Sell |
963,802
-670,950
| -41% | -$12.1M | 0.01% | 2210 |
|
|
2018
Q3 | $36.3M | Sell |
1,634,752
-685,536
| -30% | -$14.4M | 0.01% | 1748 |
|
|
2018
Q2 | $38.1M | Buy |
+2,320,288
| New | +$40.7M | 0.02% | 1692 |
|
Other funds holding AMRX
TGA
RCMNY
Dimensional Fund Advisors's AMRX Position: Q2 2026 in Review
Dimensional Fund Advisors increased its Amneal Pharmaceuticals (AMRX) stake by 1.8% in Q2 2026, buying an estimated $1.42M and bringing the position to 5,794,263 shares worth $100M. The position accounts for 0.02% of the portfolio, ranked #1174.
Dimensional Fund Advisors first reported a position in AMRX in Q2 2018 and has held it in 30 quarters since. 308 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.
- Dimensional Fund Advisors held 5,794,263 shares of Amneal Pharmaceuticals worth $100M as of Q2 2026.
- Dimensional Fund Advisors bought 103,677 Amneal Pharmaceuticals shares in Q2 2026, an estimated $1.42M.
- Amneal Pharmaceuticals made up 0.02% of Dimensional Fund Advisors's portfolio in Q2 2026, its #1174 holding.
- Dimensional Fund Advisors first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 30 quarters since.
- 308 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.
Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.